Studies have also shown overexpression of NSD2 in multifarious solid tumors, including lung cancer, prostate cancer, colorectal cancer, cervical cancer, breast cancer, and osteosarcoma.3, 4, 5, 6, 7, 8, 9, 10, 11. This evidence concerns the gene NSD2 and Familial prostate cancer.